Integra Lifesciences Holdings IART
NASDAQ IART
$16.25 -0.01 (-0.06%)
As of: Sep 9, 2026 · 3:59 PM EDT

Integra Lifesciences Holdings (IART) Revenue Growth (3y) (2012 - 2026)

Analysis

Integra Lifesciences Holdings (IART) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 8.07%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 18.10%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 8.20%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 9.66%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 14.78%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 10.83%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 4.73%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 14.51%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 8.05%
10 Integra Lifesciences Holdings 1.25 Bn 977.26 Mn 219.74 Mn 3.18%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.18%
Mar 31, 2026 0.96%
Dec 31, 2025 3.00%
Sep 30, 2025 1.44%
Jun 30, 2025 1.47%
Mar 31, 2025 0.53%
Dec 31, 2024 2.96%
Sep 30, 2024 -0.52%
Jun 30, 2024 2.35%
Mar 31, 2024 0.81%
Dec 31, 2023 0.71%
Sep 30, 2023 1.09%
Jun 30, 2023 13.81%
Mar 31, 2023 2.44%
Dec 31, 2022 0.24%
Sep 30, 2022 0.53%
Jun 30, 2022 1.22%
Mar 31, 2022 1.55%
Dec 31, 2021 1.90%
Sep 30, 2021 1.88%